Associate Director, Clinical Science
Shape the clinical and translational science strategy for BHB-1893, contributing to protocol and endpoint design, clinical data review, independent analyses, and scientific interpretation across global Phase 3 programs. Author and review clinical and regulatory documents, collaborate with internal teams and the co-development partner, and represent the program’s science to external experts and scientific audiences.